Keisuke Kida Selected Research

Furosemide (Lasix)

12/2021	Moderate potassium lowering effect of exogenous atrial natriuretic peptide in patients with acute heart failure.
3/2019	Different diuretic properties between tolvaptan and furosemide in congestive heart failure patients with diuretic resistance and renal impairment: a subanalysis of the K-STAR.
1/2019	Very Early Diuretic Response After Admission for Acute Heart Failure.
12/2018	Comparison of the effects of tolvaptan and furosemide on renal water and sodium excretion in patients with heart failure and advanced chronic kidney disease: a subanalysis of the K-STAR study.
12/2017	Effects of Additive Tolvaptan vs. Increased Furosemide on Heart Failure With Diuretic Resistance and Renal Impairment　- Results From the K-STAR Study.
6/2017	Time-to-Furosemide Treatment and Mortality in Patients Hospitalized With Acute Heart Failure.
1/2017	Effects of Tolvaptan Addition to Furosemide in Normo- and Hyponatremia Patients with Heart Failure and Chronic Kidney Disease Stages G3b-5: A Subanalysis of the K-STAR Study.
7/2015	Safety of add-on tolvaptan in patients with furosemide-resistant congestive heart failure complicated by advanced chronic kidney disease: a sub-analysis of a pharmacokinetics/ pharmacodynamics study.
3/2015	Efficacy of tolvaptan added to furosemide in heart failure patients with advanced kidney dysfunction: a pharmacokinetic and pharmacodynamic study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Keisuke Kida Research Topics

Disease

37	Heart Failure 11/2023 - 11/2008
5	Myocardial Infarction 01/2014 - 09/2010
4	Chronic Renal Insufficiency 01/2023 - 07/2015
4	Type 2 Diabetes Mellitus (MODY) 01/2023 - 01/2021
4	Body Weight (Weight, Body) 01/2021 - 03/2015
3	Cardiomyopathies (Cardiomyopathy) 10/2013 - 11/2008
2	Hyperkalemia 11/2023 - 12/2021
2	Malnutrition (Nutritional Deficiencies) 01/2023 - 01/2015
2	COVID-19 10/2022 - 05/2021
2	Atrial Fibrillation 01/2022 - 01/2021
2	Neoplasms (Cancer) 01/2021 - 12/2020
2	Spasm (Spasms) 01/2014 - 03/2003
1	Angioedema 11/2023
1	Hypotension (Low Blood Pressure) 11/2023
1	Myocardial Ischemia (Ischemic Heart Diseases) 03/2023
1	Hyperuricemia 01/2023
1	Hypertension (High Blood Pressure) 01/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2022
1	Obesity 07/2022
1	Jaundice (Icterus) 07/2022
1	Premature Birth (Birth, Premature) 07/2022
1	Ventricular Tachycardia 01/2022
1	Dermatitis 01/2022
1	Ischemic Stroke 01/2022
1	Hypokalemia 12/2021
1	Frailty 07/2021
1	Hepatocellular Carcinoma (Hepatoma) 01/2021
1	Left Ventricular Dysfunction 01/2021
1	Hemangioma (Angioma) 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Aortic Valve Stenosis (Aortic Stenosis) 12/2020
1	ST Elevation Myocardial Infarction 11/2020
1	Non-ST Elevated Myocardial Infarction 11/2020
1	Acute Coronary Syndrome 11/2020
1	Liver Diseases (Liver Disease) 09/2020
1	Hyponatremia 01/2017

Drug/Important Bio-Agent (IBA)

9	Furosemide (Lasix)FDA LinkGeneric 12/2021 - 03/2015
7	DiureticsIBA 01/2023 - 12/2017
6	Tolvaptan FDA Link 03/2019 - 03/2015
5	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2023 - 01/2020
3	CanagliflozinIBA 01/2023 - 01/2021
3	ElectrolytesIBA 01/2023 - 07/2015
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 09/2019
3	Atrial Natriuretic Factor (ANF)IBA 12/2022 - 12/2020
3	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 03/2019 - 07/2015
3	Fatty Acids (Saturated Fatty Acids)IBA 01/2014 - 04/2007
3	CatecholaminesIBA 01/2010 - 03/2003
2	sacubitril and valsartan sodium hydrate drug combinationIBA 11/2023 - 12/2022
2	SaltsIBA 01/2023 - 01/2021
2	pro-brain natriuretic peptide (1-76)IBA 07/2022 - 01/2021
2	BilirubinIBA 07/2022 - 09/2020
2	edoxabanIBA 01/2022 - 01/2021
2	LipidsIBA 11/2020 - 01/2006
2	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2014 - 03/2003
2	Carvedilol (Coreg)FDA LinkGeneric 10/2013 - 09/2013
2	GadoliniumIBA 10/2013 - 09/2013
2	EnzymesIBA 12/2011 - 02/2011
2	Technetium Tc 99m Sestamibi (Cardiolite)FDA LinkGeneric 12/2011 - 02/2011
2	AcidsIBA 06/2011 - 11/2008
1	IvabradineIBA 04/2023
1	ChloridesIBA 01/2023
1	finerenoneIBA 01/2023
1	Sodium-Glucose Transport ProteinsIBA 01/2023
1	Hormones (Hormone)IBA 12/2022
1	Sodium-Glucose Transporter 2 InhibitorsIBA 07/2022
1	glimepiride (Amarel)FDA LinkGeneric 07/2022
1	GlucocorticoidsIBA 07/2022
1	fibrin fragment D (D-dimer)IBA 01/2022
1	AnticoagulantsIBA 01/2022
1	human NPPA protein (carperitide)IBA 01/2022
1	PotassiumIBA 12/2021
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 12/2021
1	Natriuretic PeptidesIBA 12/2021
1	Neprilysin (Neutral Endopeptidase)IBA 12/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	CytokinesIBA 01/2021
1	InterleukinsIBA 01/2021
1	Macrophage Migration-Inhibitory FactorsIBA 01/2021
1	Interleukin-16 (Interleukin 16)IBA 01/2021
1	AlbuminsIBA 09/2020
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 12/2019
1	Angiotensin Receptor AntagonistsIBA 12/2019
1	SodiumIBA 12/2018
1	Vasodilator Agents (Vasodilators)IBA 01/2018
1	CreatinineIBA 12/2017
1	Prealbumin (Transthyretin)IBA 01/2015

Therapy/Procedure

8	Cardiac Rehabilitation 03/2023 - 09/2012
4	Patient Readmission 11/2023 - 01/2022
4	Therapeutics 03/2023 - 01/2018
3	Drug Therapy (Chemotherapy) 04/2023 - 01/2006
2	Transcatheter Aortic Valve Replacement 07/2021 - 12/2020
2	Percutaneous Coronary Intervention 06/2011 - 02/2011
1	Exercise Therapy (Therapy, Exercise) 01/2023
1	Telerehabilitation 01/2023
1	Secondary Prevention 01/2023
1	Activities of Daily Living (ADL) 01/2023
1	Radiofrequency Ablation 01/2022
1	Transplantation 01/2021
1	Palliative Care (Palliative Therapy) 04/2020